meta_pixel
Tapesearch Logo
Log in
City Journal Audio

Prescription Drugs and Price Controls

City Journal Audio

Manhattan Institute

News, News Commentary, Politics

4.7657 Ratings

🗓️ 12 December 2018

⏱️ 16 minutes

🧾️ Download transcript

Summary

John Tierney joins City Journal editor Brian Anderson to discuss what the debate over prescription drugs gets wrong and the cost that government-imposed price controls could have on one of the world's most innovative industries.

The business practices of the pharmaceutical industry--or "Big Pharma"—are one of the most divisive political issues of our time. Leaders from both political parties, from Bernie Sanders to President Trump, regularly denounce drug companies for profiteering and call for lower drug prices. But as Tierney notes in City Journal, "of every dollar that Americans spend on health, only a dime goes for prescription drugs. The lion's share of health spending goes to hospitals and people in the health-care professions."

America has been called the "Pharmacy to the World" because it's where more than half of new drugs get developed and tested in clinical trials. Patients in Europe and elsewhere enjoy the benefits of these breakthrough drugs. Price controls in the U.S. would significantly curtail new research and development projects--resulting in a net loss for everyone.

Transcript

Click on a timestamp to play from that location

0:00.0

Welcome back to the Ten Blocks podcast. This is your host, Brian Anderson, the editor of City Journal.

0:06.6

The cost of prescription drugs has become one of the hot political issues of our time.

0:11.8

Progressive politicians like Bernie Sanders and Elizabeth Warren have called for strict regulation of prescription drug prices.

0:18.7

And as the midterm results indicate, their ranks in Congress

0:21.6

are going to grow next session. But Donald Trump, too, has grumbled about drug prices,

0:26.6

and at times has threatened drug companies with further regulation to keep those prices reasonably low.

0:33.6

The pharmaceutical industry has been a target of criticism and public anger for decades over what are

0:39.4

deemed excessive prices, and the anger is understandable, since people's health can often depend

0:45.2

on a regular supply of drugs. Few people understand how drug development works, however.

0:52.6

A new drug, for example, takes often more than a decade to

0:56.1

bring to market, and the potential for financial losses can be enormous. So that's why we invited

1:02.2

John Tierney, City Journal contributing editor, to talk about his piece in the new issue of

1:07.8

City Journal, what the prescription drug debate gets wrong. It's a masterful and clear

1:12.7

discussion of what's at stake in this very important debate. After the music, we'll talk with

1:18.2

John Tierney. We hope you enjoy. Hello again, everyone. This is Brian Anderson, the editor of City Journal.

1:44.0

Joining me on the show today is John Tierney. John is a contributing editor at City Journal,

1:48.9

and before joining us, he was a reporter and columnist for many years at the New York Times,

1:54.3

and he is a best-selling author. His latest piece for City Journal is called What the Prescription Drug Debate gets wrong,

2:01.9

and it appears in our autumn 2018 issue.

2:06.2

John, thanks for joining us.

2:07.6

Thanks, Brian.

2:08.9

Now, critics of the pharmaceutical industry, Big Pharma, as they often call it,

...

Please login to see the full transcript.

Disclaimer: The podcast and artwork embedded on this page are from Manhattan Institute, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of Manhattan Institute and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.

Copyright © Tapesearch 2026.